机构：[1]Samuel Oschin Comprehensive Cancer Institute, Department of Medicine, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.[2]Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.[3]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.四川大学华西医院[4]Department of Pathology, Ningbo Diagnostic Pathology Center, Ningbo, 315021, China.[5]Department of Public Research Platform, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, 317000, China.台州恩泽医疗中心台州医院[6]Department of Rehabilitation, West Kyushu University, Kanzaki-shi, 842-8585, Japan.[7]Department of Urology, Kyung Hee University, Seoul, 446 701, South Korea.[8]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
This program was supported by the
Chinese Scholarship Council (Grant No. 202206240086), the
National Natural Science Foundation of China (Grant No.
82170432) and programs from Science and Technology
Department of Sichuan Province (Grant No.
2020YFSY0024).
第一作者机构：[1]Samuel Oschin Comprehensive Cancer Institute, Department of Medicine, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Ye Xing,Tuo Zhouting,Chen Kai,et al.Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF)[J].Oncology Research.2024,32(3):503-515.doi:10.32604/or.2024.045050.
APA：
Ye Xing,Tuo Zhouting,Chen Kai,Wu Ruicheng,Wang Jie...&Feng Dechao.(2024).Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF).Oncology Research,32,(3)
MLA：
Ye Xing,et al."Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF)".Oncology Research 32..3(2024):503-515
